In a move that blurs the lines between public health research and military preparedness, the National Institutes of Health (NIH) has reached an agreement with the Department of Defense (DoD) that will see part of the NIH's budget used to fund Pentagon projects. The agreement, signed roughly a month ago, was quietly released by the DoD on the Friday before a US holiday weekend, according to documents reviewed by Ars Technica and initially revealed by the journal Nature.

The arrangement sets up a system in which the NIH will transfer money to the DoD to fund staff and projects that "support the advanced development of medical countermeasures against pandemic influenza, chemical, biological, radiological, and nuclear (CBRN) threats, and emerging infectious diseases". The funds will come from the budget of the National Institute of Allergy and Infectious Diseases (NIAID), which Congress has allocated $6.6 billion for in 2026. The agreement will run for a decade, and the exact amount to be transferred remains unspecified.

Pentagon sought a larger cut

According to reporting by Nature, the DoD initially sought up to a third of NIAID's total budget but was told to settle for about 10 percent. Even that figure would represent a substantial shift—potentially hundreds of millions of dollars per year—from biomedical research traditionally focused on civilian health threats to programs with a national security rationale.

Critics inside and outside Congress have reacted with alarm. Representative Rosa DeLauro of Connecticut, the top Democrat on the House Appropriations Committee, condemned the agreement as "secretive" and warned that it would divert precious NIH funds away from public health priorities. Her remarks echo concerns that the current NIH leadership—under the Trump administration's influence—has explicitly rejected some projects that fall under the new DoD scope. The agreement could thereby fund research that the NIH itself has deemed less scientifically meritorious.

"This agreement was negotiated behind closed doors and would force NIAID to foot the bill for Pentagon projects that have not gone through the scientific peer-review process," said DeLauro in a statement.

Budget disparities and mission creep

The fiscal asymmetry between the two agencies is striking. The NIH's overall budget exceeds $47 billion, while the DoD receives roughly $850 billion annually—yet the Pentagon is seeking additional resources from a health agency already straining to maintain its core mission. NIAID, led by Dr. Anthony Fauci until late 2022, has historically focused on infectious diseases like HIV, malaria, and emerging threats such as Zika and COVID-19. Diverting up to 10 percent of its budget could force difficult choices for research programs with no direct military application.

The agreement stipulates that DoD staff and projects would receive funds for "advanced development" of countermeasures. This is a later-stage research phase, closer to product development and regulatory approval, rather than basic science. Some experts note that advanced development is often costly and risky, and that the Pentagon has its own agencies—such as the Defense Advanced Research Projects Agency (DARPA) and the Defense Threat Reduction Agency—already equipped to handle such work. Why it would need to tap NIH funds remains unclear.

Transparency questions surrounding a secretive deal

The rollout of the agreement has done little to allay concerns. Although the DoD released a copy late Friday, the move came without a formal announcement from the NIH or a public explanation. The timing—on the cusp of the holiday weekend—suggests an attempt to minimize news coverage, critics say. Nature reported that the agreement had been signed about a month before it became public, and the Pentagon had been circumspect about its existence.

Congressional oversight could complicate implementation. While the arrangement may technically fall within the NIH's appropriations law, lawmakers on both sides have historically been protective of the agency's independence. "This is a dangerous precedent," said one former NIH senior official, speaking on condition of anonymity. "It treats NIH as an ATM for other agencies, and once that door opens, it's hard to close."

What happens next?

The memorandum of agreement is scheduled to cover a decade, meaning its effects will be felt across multiple presidential administrations and Congresses. Given the current political climate—where health budgets are already under scrutiny—the deal could face litigation or legislative challenges. Some appropriators are likely to attach riders to future funding bills to block the transfer.

The broader implication, analysts say, is the continued militarization of health research. As the Department of Defense seeks to prepare for biological threats and potential intentional outbreaks, the boundary between medical research for public health and for military advantage may become increasingly blurred. For NIAID, whose mission is to protect human health regardless of national affiliation, the arrangement raises moral and practical questions about its global role.

The story is still developing, and neither the NIH nor the DoD has issued a public statement beyond the released document. But the agreement signals a significant shift: in the face of fiscal constraints, the Pentagon is borrowing from the nation's premier health research agency—and the NIH leadership is, at least for now, allowing it.